• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Monday

    2/28/22 10:43:34 AM ET
    $AAOI
    $ALPA
    $AMBC
    $AMYT
    Semiconductors
    Technology
    Medical/Dental Instruments
    Health Care
    Get the next $AAOI alert in real time by email

     

    On Monday morning, 66 companies achieved new lows for the year.

    Noteable 52-Week Lows:

    • Gilead Sciences (NASDAQ:GILD) was the largest firm on a market cap basis to set a new 52-week low.
    • Tenax Therapeutics (NASDAQ:TENX) was the smallest company when considering market cap to set a new 52-week low.
    • Esports Entertainment (NASDAQ:GMBL) was the biggest loser of the morning session, as it dropped 34.48% to reach its new 52-week low.
    • Morgan Stanley Emerg Mkts (NYSE:MSD) shares were the most resilient of the group, as shares actually moved up 0.58% in response to hitting its 52-week low.

    The following stocks achieved new 52-week lows during the first half-hour of trading on Monday:

    • Gilead Sciences (NASDAQ:GILD) stock achieved a new 52-week low on Monday morning, hitting $59.22 and moving down 2.55%.
    • PPG Industries (NYSE:PPG) shares set a new 52-week low of $133.23. The stock traded down 4.7%.
    • Telefonaktiebolaget L M (NASDAQ:ERIC) shares were down 8.7% for the day, having made a 52-week low of $9.18.
    • EPAM Systems (NYSE:EPAM) shares set a new 52-week low of $290.00. The stock traded down 16.73%.
    • Viatris (NASDAQ:VTRS) shares set a new 52-week low of $11.04. The stock traded down 21.42%.
    • MasTec (NYSE:MTZ) stock drifted down 2.45% on Monday morning to hit a new 52-week low of $75.61.
    • Physicians Realty Trust (NYSE:DOC) shares were down 3.51% for the day, having made a 52-week low of $16.29.
    • Blueprint Medicines (NASDAQ:BPMC) shares reached a new 52-week low of $60.37 on Monday morning, moving down 1.52%.
    • Quaker Houghton (NYSE:KWR) shares reached a new 52-week low of $185.01 on Monday morning, moving down 1.96%.
    • Vir Biotechnology (NASDAQ:VIR) shares hit a yearly low of $24.62. The stock was down 10.42% on the session.
    • Cazoo Gr (NYSE:CZOO) stock dropped to a yearly low on Monday of $3.35. Shares traded down 9.79%.
    • BRF (NYSE:BRFS) stock hit $3.16 on Monday morning, setting a new 52-week low for a change of down 2.91%.
    • Qurate Retail (NASDAQ:QRTEA) stock hit a yearly low of $5.40. The stock was down 7.12% for the day.
    • Itron (NASDAQ:ITRI) shares made a new 52-week low of $45.12 on Monday. The stock was down 15.46% for the day.
    • Itau Corpbanca (NYSE:ITCB) shares set a new yearly low of $2.70 this morning. The stock was down 3.45% on the session.
    • LumiraDx (NASDAQ:LMDX) stock set a new 52-week low of $6.87 on Monday, moving up 1.17%.
    • Wolverine World Wide (NYSE:WWW) stock hit a new 52-week low of $22.67. The stock was down 2.13% on the session.
    • Green Dot (NYSE:GDOT) shares reached a new 52-week low of $25.81 on Monday morning, moving up 0.78%.
    • Allbirds (NASDAQ:BIRD) stock achieved a new 52-week low on Monday morning, hitting $7.46 and moving down 3.44%.
    • Reata Pharmaceuticals (NASDAQ:RETA) shares set a new yearly low of $22.71 this morning. The stock was up 14.81% on the session.
    • VEON (NASDAQ:VEON) stock hit a new 52-week low of $0.57. The stock was down 28.64% on the session.
    • Cano Health (NYSE:CANO) stock broke to a new 52-week low of $4.49 on Monday. Shares of the company traded down 11.56%.
    • Tucows (NASDAQ:TCX) stock broke to a new 52-week low of $65.78 on Monday. Shares of the company traded down 1.28%.
    • MannKind (NASDAQ:MNKD) stock hit $2.49 on Monday morning, setting a new 52-week low for a change of down 6.8%.
    • Ambac Financial Group (NYSE:AMBC) shares fell to $12.77 on Monday, setting a new 52-week low with a shift of down 0.94%.
    • DMC Glb (NASDAQ:BOOM) stock set a new 52-week low of $30.85 on Monday, moving down 3.28%.
    • Orchid Island Capital (NYSE:ORC) shares set a new 52-week low of $3.27. The stock traded down 3.5%.
    • Home Point Capital (NASDAQ:HMPT) stock achieved a new 52-week low on Monday morning, hitting $3.16 and moving down 8.06%.
    • Missfresh (NASDAQ:MF) shares fell to $1.75 on Monday, setting a new 52-week low with a shift of down 6.32%.
    • Amryt Pharma (NASDAQ:AMYT) shares set a new yearly low of $5.61 this morning. The stock was down 20.05% on the session.
    • Angel Oak Mortgage (NYSE:AOMR) shares set a new 52-week low of $15.64. The stock traded down 4.94%.
    • Kinnate Biopharma (NASDAQ:KNTE) shares moved down 4.74% on Monday to hit a new 52-week low of $7.83, drifting down 4.74%.
    • Lexicon Pharmaceuticals (NASDAQ:LXRX) stock broke to a new 52-week low of $2.11 on Monday. Shares of the company traded down 21.75%.
    • Marinus Pharmaceuticals (NASDAQ:MRNS) shares made a new 52-week low of $7.66 on Monday. The stock was down 5.55% for the day.
    • Pioneer Bancorp (NASDAQ:PBFS) shares fell to $10.50 on Monday, setting a new 52-week low with a shift of down 0.84%.
    • Opthea (NASDAQ:OPT) stock set a new 52-week low of $5.49 on Monday, moving down 7.68%.
    • Ikena Oncology (NASDAQ:IKNA) shares fell to $6.05 on Monday, setting a new 52-week low with a shift of down 7.33%.
    • Zevia (NYSE:ZVIA) shares made a new 52-week low of $6.06 on Monday. The stock was down 7.95% for the day.
    • Annexon (NASDAQ:ANNX) shares fell to $4.96 on Monday, setting a new 52-week low with a shift of down 3.11%.
    • Alpha Healthcare (NASDAQ:ALPA) shares hit a yearly low of $9.58. The stock was down 0.62% on the session.
    • 9 Meters Biopharma (NASDAQ:NMTR) shares made a new 52-week low of $0.54 on Monday. The stock was down 4.21% for the day.
    • Vincerx Pharma (NASDAQ:VINC) stock hit a yearly low of $4.93. The stock was down 5.17% for the day.
    • Randolph Bancorp (NASDAQ:RNDB) stock achieved a new 52-week low on Monday morning, hitting $18.18 and moving down 6.51%.
    • CENTRAL & EASTERN EUROPE (NYSE:CEE) stock set a new 52-week low of $15.90 on Monday, moving down 14.73%.
    • Frequency Therapeutics (NASDAQ:FREQ) stock broke to a new 52-week low of $2.77 on Monday. Shares of the company traded down 3.28%.
    • Applied Optoelectronics (NASDAQ:AAOI) stock drifted down 3.04% on Monday morning to hit a new 52-week low of $3.34.
    • Better Therapeutics (NASDAQ:BTTX) stock broke to a new 52-week low of $2.85 on Monday. Shares of the company traded up 2.73%.
    • Lixiang Education Holding (NASDAQ:LXEH) stock dropped to a yearly low on Monday of $4.96. Shares traded down 9.49%.
    • Celyad Oncology (NASDAQ:CYAD) shares fell to $2.78 on Monday, setting a new 52-week low with a shift of down 10.25%.
    • First Trust/aberdeen (NYSE:FEO) shares made a new 52-week low of $11.63 on Monday. The stock was down 3.2% for the day.
    • Troika Media Group (NASDAQ:TRKA) stock hit a yearly low of $0.84. The stock was down 7.23% for the day.
    • NextPlat (NASDAQ:NXPL) stock dropped to a yearly low on Monday of $2.82. Shares traded up 1.83%.
    • Trinity Biotech (NASDAQ:TRIB) shares were up 1.24% for the day, having made a 52-week low of $1.01.
    • Esports Entertainment (NASDAQ:GMBL) shares reached a new 52-week low of $0.70 on Monday morning, moving down 34.48%.
    • Benitec Biopharma (NASDAQ:BNTC) stock broke to a new 52-week low of $2.10 on Monday. Shares of the company traded down 3.83%.
    • Versus Systems (NASDAQ:VS) shares set a new yearly low of $1.09 this morning. The stock was down 3.48% on the session.
    • Kidpik (NASDAQ:PIK) stock hit $1.89 on Monday morning, setting a new 52-week low for a change of down 18.37%.
    • Tenax Therapeutics (NASDAQ:TENX) stock dropped to a yearly low on Monday of $0.55. Shares traded down 8.17%.

     

    Be sure to monitor Benzinga for the news traders need! And for even more up-to-date info on 52-week lows and highs, check out Benzinga Pro. This cutting-edge market research platform alerts traders of which stocks are trading near their 52-week highs and lows each morning - and delivers lots of other actionable data. Learn more here.

    Get the next $AAOI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AAOI
    $ALPA
    $AMBC
    $AMYT

    CompanyDatePrice TargetRatingAnalyst
    Healthpeak Properties Inc.
    $DOC
    2/5/2026Buy → Hold
    Argus
    Allbirds Inc.
    $BIRD
    2/4/2026Buy → Hold
    Maxim Group
    MasTec Inc.
    $MTZ
    1/23/2026$274.00Overweight
    Cantor Fitzgerald
    Wolverine World Wide Inc.
    $WWW
    1/23/2026$19.00Outperform → Neutral
    BNP Paribas Exane
    Wolverine World Wide Inc.
    $WWW
    1/23/2026Buy → Hold
    Argus
    Viatris Inc.
    $VTRS
    1/16/2026$15.00Hold → Buy
    Argus
    Zevia PBC
    $ZVIA
    1/15/2026$4.00Buy
    Craig Hallum
    Healthpeak Properties Inc.
    $DOC
    1/9/2026$17.00Neutral
    Goldman
    More analyst ratings

    $AAOI
    $ALPA
    $AMBC
    $AMYT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Healthpeak Properties downgraded by Argus

    Argus downgraded Healthpeak Properties from Buy to Hold

    2/5/26 8:46:47 AM ET
    $DOC
    Real Estate Investment Trusts
    Real Estate

    Allbirds downgraded by Maxim Group

    Maxim Group downgraded Allbirds from Buy to Hold

    2/4/26 8:06:33 AM ET
    $BIRD
    Apparel
    Consumer Discretionary

    Cantor Fitzgerald initiated coverage on MasTec with a new price target

    Cantor Fitzgerald initiated coverage of MasTec with a rating of Overweight and set a new price target of $274.00

    1/23/26 8:20:09 AM ET
    $MTZ
    Water Sewer Pipeline Comm & Power Line Construction
    Industrials

    $AAOI
    $ALPA
    $AMBC
    $AMYT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO O'Day Daniel Patrick exercised 115,640 shares at a strike of $66.01 and sold $17,346,000 worth of shares (115,640 units at $150.00) (SEC Form 4)

    4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)

    2/6/26 4:22:37 PM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Comm & Corp Aff Officer Mercier Johanna was granted 44,867 shares and covered exercise/tax liability with 24,800 shares, increasing direct ownership by 19% to 123,288 units (SEC Form 4)

    4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)

    2/5/26 6:51:29 PM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Financial Officer Dickinson Andrew D was granted 44,867 shares and covered exercise/tax liability with 24,802 shares, increasing direct ownership by 13% to 170,568 units (SEC Form 4)

    4 - GILEAD SCIENCES, INC. (0000882095) (Issuer)

    2/5/26 6:49:59 PM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAOI
    $ALPA
    $AMBC
    $AMYT
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-6) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/25/2024. Application Category: NDA, Application Number: 215973, Application Classification: Efficacy

    11/26/24 4:36:21 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-8) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/25/2024. Application Category: NDA, Application Number: 215974, Application Classification: Efficacy

    11/26/24 4:36:21 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    FDA Approval for SUNLENCA issued to GILEAD SCIENCES INC

    Submission status for GILEAD SCIENCES INC's drug SUNLENCA (SUPPL-9) with active ingredient LENACAPAVIR SODIUM has changed to 'Approval' on 11/13/2024. Application Category: NDA, Application Number: 215973, Application Classification: Manufacturing (CMC)

    11/15/24 4:36:27 AM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AAOI
    $ALPA
    $AMBC
    $AMYT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    VEON and JazzWorld Launch "Invest in Pakistan, NOW!" Inviting International Investors to Participate in Pakistan's Growth

    Dubai, New York and Islamabad, 8 February 2026: VEON Ltd. (NASDAQ:VEON), a global digital operator ("VEON" or the "Group"), today announced the launching of its "Invest in Pakistan, NOW!" initiative in partnership with JazzWorld, VEON's services company in Pakistan, during World Governments Summit in Dubai, UAE. "Invest in Pakistan, NOW!" invites international investors to take a fresh look at Pakistan as the country's economic fundamentals strengthen, and long-term growth opportunities become more visible. As a part of the initiative, JazzWorld and Nutshell Group of Pakistan, signed a Memorandum of Understanding (MoU) to advance dialogue and partnerships around digitalization, inclusive gr

    2/8/26 5:00:00 AM ET
    $VEON
    Telecommunications Equipment
    Telecommunications

    Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

    THE WOODLANDS, Texas, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) ("Lexicon") today announced the closing of its previously announced underwritten public offering of 32,000,000 shares of its common stock, par value $0.001, and concurrent private placement of 22,400,000 shares of common stock and 367,145 shares of series b convertible preferred stock (the "Series B Convertible Preferred Stock"). The shares of common stock offered pursuant to the public offering were sold at a public offering price of $1.30 per share and the shares of preferred stock were sold at a price of $65 per share. The offerings closed on February 2, 2026. In addition to the shares s

    2/6/26 5:17:00 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    MERRELL EXPANDS SKYRUNNER WORLD SERIES PARTNERSHIP WITH A US NATIONAL SERIES, AND LAUNCH OF THE AGILITY PEAK 6

    Rockford, Michigan, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Merrell, the world's leading hiking and outdoor footwear brand, launched today its all-new Agility Peak 6 and announced the new Merrell U.S. Skyrunner National Series. As the brand marks 45 years on the trail, the new national series circuit, expanded world series partnership, and latest innovative trail shoe reinforce Merrell's deep commitment to performance trail running and advancing the sport at its highest levels. Merrell's long-standing sponsorship of the Skyrunner World Series has always underscored the brand's work enabling people to push themselves to the limits of human performance.  To address the gap in Skyrunning oppor

    2/6/26 9:03:00 AM ET
    $WWW
    Shoe Manufacturing
    Consumer Discretionary

    $AAOI
    $ALPA
    $AMBC
    $AMYT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Invus Global Management, Llc was granted 22,400,000 shares, bought $2,000,001 worth of shares (1,538,462 units at $1.30) and was granted 367,145 units of Series B Convertible Preferred Stock (SEC Form 4)

    4 - LEXICON PHARMACEUTICALS, INC. (0001062822) (Issuer)

    2/4/26 4:25:05 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Carson William H. bought $20,657 worth of shares (4,115 units at $5.02), increasing direct ownership by 8% to 54,405 units (SEC Form 4)

    4 - Annexon, Inc. (0001528115) (Issuer)

    1/2/26 4:30:06 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Suvretta Capital Management, Llc bought $1,903,133 worth of shares (144,223 units at $13.20) (SEC Form 4)

    4 - Benitec Biopharma Inc. (0001808898) (Issuer)

    12/29/25 7:31:28 PM ET
    $BNTC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ALPA
    $AMBC
    $AMYT
    SEC Filings

    View All

    SEC Form FWP filed by Lexicon Pharmaceuticals Inc.

    FWP - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    2/6/26 5:17:30 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SCHEDULE 13G filed by Gilead Sciences Inc.

    SCHEDULE 13G - GILEAD SCIENCES, INC. (0000882095) (Subject)

    2/5/26 1:23:14 PM ET
    $GILD
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Annexon Inc.

    SCHEDULE 13G/A - Annexon, Inc. (0001528115) (Subject)

    2/5/26 1:16:32 PM ET
    $ANNX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AAOI
    $ALPA
    $AMBC
    $AMYT
    Leadership Updates

    Live Leadership Updates

    View All

    Viatris Appoints Matthew J. Maletta as Chief Legal Officer

    Brian Roman to Leave the Company After More Than 20 Years of Exemplary Service; Will Remain Advisor Through Transition Period  PITTSBURGH, Feb. 3, 2026 /PRNewswire/ -- Viatris Inc. (NASDAQ:VTRS) announced today that Matthew J. Maletta has been appointed Chief Legal Officer (CLO), effective February 9, 2026. The appointment follows the transition of the Company's current CLO, Brian Roman, after more than 20 years of exemplary service to Viatris and its predecessor company, Mylan. Roman, who has served in multiple leadership positions and played a key role in supporting the Company's operations, portfolio and growth initiatives, will stay on through April 1, 2026, to ensure a smooth transition

    2/3/26 8:30:00 AM ET
    $VTRS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dye & Durham Appoints Allen Taylor to the Board

    TORONTO, Jan. 27, 2026 /CNW/ - Dye & Durham Limited ("Dye & Durham" or the "Company") (TSX:DND), a leading provider of cloud-based legal-practice-management software, today announced that it has temporarily increased the number of directors of the Company to eight and appointed Allen Taylor to the board of directors of the Company (the "Board"). The increase in the number of directors of the Company was agreed to by each of Plantro Ltd. and OneMove Capital Ltd. in accordance with the terms of the respective agreements to which it is party with the Company. Prior to his appointment as a director of the Company, Mr. Taylor served as an observer to the Board. As previously announced, Mr. Taylo

    1/27/26 4:55:00 PM ET
    $TCX
    EDP Services
    Technology

    EPAM to Host Investor Day on March 12, 2026

    Sharing Long-Term Growth Strategy for the Next Wave of AI-Driven Business Transformation NEWTOWN, Pa., Jan. 13, 2026 /PRNewswire/ -- EPAM Systems, Inc. (NYSE: EPAM), a leading digital and AI transformation company, will host an Investor Day in Boston on March 12, 2026. The event will feature remarks by EPAM's Chief Executive Officer and President, Balazs Fejes, and Chief Financial Officer, Jason Peterson, as well as other members of the executive leadership team. "Our Investor Day is an opportunity to demonstrate the solid progress we've made against our long-term strategic pr

    1/13/26 8:02:00 AM ET
    $EPAM
    EDP Services
    Technology

    $AAOI
    $ALPA
    $AMBC
    $AMYT
    Financials

    Live finance-specific insights

    View All

    Bimini Capital Management to Announce Fourth Quarter 2025 Results

    VERO BEACH, Fla., Feb. 06, 2026 (GLOBE NEWSWIRE) -- Bimini Capital Management, Inc. (OTCQB:BMNM) ("Bimini" or the "Company"), today announced that it will release results for the fourth quarter of 2025 following the close of trading on Thursday, March 5, 2026. Earnings Conference Call Details An earnings conference call and live audio webcast will be hosted Friday, March 6, 2026, at 10:00 AM ET. Participants can register and receive dial-in information at https://register-conf.media-server.com/register/BI5b52747f39b248e6bdb12a6e39cbfd09. A live audio webcast of the conference call can be accessed at https://edge.media-server.com/mmc/p/u2f5cgxh or via the investor relations section of the

    2/6/26 8:36:12 AM ET
    $ORC
    Real Estate Investment Trusts
    Real Estate

    Applied Optoelectronics Announces Date of Fourth Quarter and Full Year 2025 Financial Results Conference Call

    SUGAR LAND, Texas, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Applied Optoelectronics, Inc. (NASDAQ:AAOI) ("AOI"), a leading provider of advanced optical and HFC networking products that power the internet, today announced that it will release financial results for its fourth quarter and full year ended December 31, 2025, on Thursday, February 26, 2026. AOI will host a conference call and webcast for analysts and investors to discuss its fourth quarter and full year 2025 financial results and outlook for its first quarter 2026 at 4:30 p.m. Eastern Time / 3:30 p.m. Central Time the same day. To participate in the call, please dial 844-890-1794 and ask to be joined to the AOI call. A live audio web

    2/5/26 4:15:00 PM ET
    $AAOI
    Semiconductors
    Technology

    Angel Oak Mortgage REIT, Inc. Declares Quarterly Common Stock Dividend

    Angel Oak Mortgage REIT, Inc. (NYSE:AOMR) (the "Company," "we," and "our"), a leading real estate finance company focused on acquiring and investing in first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market, today announced that its Board of Directors has declared a quarterly cash dividend. Common Stock Dividend The Board has declared a dividend of $0.32 per share of common stock. The dividend is payable on February 27th, 2026 to common stockholders of record as of February 20th, 2026. About Angel Oak Mortgage REIT, Inc. Angel Oak Mortgage REIT, Inc. is a real estate finance company focused on acquiring and investing in first lien non-QM loans and other mo

    2/5/26 4:05:00 PM ET
    $AOMR
    Real Estate
    Finance

    $AAOI
    $ALPA
    $AMBC
    $AMYT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/17/24 4:18:46 PM ET
    $KWR
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Quaker Houghton

    SC 13D/A - QUAKER CHEMICAL CORP (0000081362) (Subject)

    12/12/24 4:59:11 PM ET
    $KWR
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13D/A filed by Lexicon Pharmaceuticals Inc.

    SC 13D/A - LEXICON PHARMACEUTICALS, INC. (0001062822) (Subject)

    12/9/24 9:33:20 PM ET
    $LXRX
    Biotechnology: Pharmaceutical Preparations
    Health Care